Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile Johnson and Johnson announced that it will acquire Momenta Pharmaceuticals for an all cash transaction worth of $6.5 billion. Momenta Pha...
US FDA approved another drug for rare Duchenne Muscular Dystrophy The United States Food and Drug Administration has approved Viltepso (viltolarsen) for treating patients suffering from Duchenne muscular...
Gilead submitted NDA for Veklury to treat COVID-19 in the US Gilead has submitted a New Drug Application (NDA) for Veklury (remdesivir) to the Food and Drug Administration (FDA) for treating patient...
FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy The United States Food and Drug Administration has approved Evrysdi (risdiplam) for the treatment of Spinal Muscular Atrophy (SMA) in adu...
NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS Novartis has announced that Cosentyx (secukinumab) received approval from the European Commission for the treatment of moderate-to-severe...
GSK’s first anti-BCMA therapy Blenrep was approved in the US GSK has announced that it has received the approval for Blenrep (belantamab mafodotin-blmf) as monotherapy for adult patients suffering f...
Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma The United States Food and Drug Administration approved Gilead’s cell-based gene therapy Tecartus (brexucabtagene autoleucel). The drug a...
Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA Gilead has announced that it has received the approval for Jyseleca (filgotinib) from the regulatory authorities in the European Union an...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19 p...
Astellas received approval for Xtandi in Japan for prostate cancer Astellas announced that it had received approval from Japan Ministry of Health, Labour and Welfare (MHLW) for Xtandi (enzalutamide) for t...
Gilead’s Veklury (remdesivir) approved by Japan’s MHLW for COVID-19 Gilead has announced that the Japanese Ministry of Health, Labor and Welfare approved Veklury (remdesivir) for severe COVID-19. The drug ...
TGA approved Novartis Luxturna in Australia Australian Therapeutic Goods Administration has approved Luxturna (voretigene neparvovec) for treating patients with inherited retinal dy...
Roche’s Rozlytrek approved in Australia for ROS1 positive NSCLC Australia’s Therapeutic Goods Administration has approved Rozlytrek (entrectinib) for treating patients suffering from ROS1 positive non-...
ipharmaservices Aug 25 2 min Merck’s Keytruda received one more indication and dosage form approval in Japan
ipharmaservices Aug 22 2 min AZ received one more approval in Japan, received approval of Imfinzi for SCLC
ipharmaservices Aug 12 1 min China’s National Medicinal Products Administration approved Gilead’s Truvada
